Drug Database
Back to search

France· FR:61381765

ERYLIK, gel pour application cutanée

A medicinal product containing trétinoïne + érythromycine, registered in France by LABORATOIRES BAILLEUL (LUXEMBOURG).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedERYLIK, gel pour application cutanéeATC—REGISTER NO.FR:61381765PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trétinoïne + érythromycineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TRÉTINOÏNE + ÉRYTHROMYCINE
Manufacturer
LABORATOIRES BAILLEUL (LUXEMBOURG)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400934243448
    1 tube(s) aluminium de 30 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trétinoïne + érythromycine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trétinoïne + érythromycine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Czechia · Aknemycin Plus
  • Germany · Aknemycin Plus
  • United Kingdom (Northern Ireland) · Aknemycin Plus
  • Greece · Acmefront, Erytin-Acn
  • Poland · Aknemycin Plus
  • Slovakia · Aknemycin Plus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7301541-8078-495e-a25a-47dd6d335853
GET /v1/drugs/f7301541-8078-495e-a25a-47dd6d335853?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61381765",
  "date_amm": "1997-02-19",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "TRÉTINOÏNE + ÉRYTHROMYCINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gel pour application",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about trétinoïne + érythromycine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console